[AVTE] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
29-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -15.34%
YoY- -82.68%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -19,563 -19,025 -16,520 -14,997 -13,588 -11,991 -10,910 47.54%
Tax -25 -1,312 -1,119 25 -564 -224 -109 -62.49%
NP -19,563 -19,025 -15,401 -15,022 -13,024 -11,767 -10,801 48.53%
Tax Rate - - - - - - - -
Total Cost 19,563 19,025 15,401 15,022 13,024 11,767 10,801 48.53%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.71 -0.76 -0.62 -0.61 -0.53 -0.48 -0.44 37.53%
EPS Diluted -0.71 -0.76 -0.62 -0.61 -0.53 -0.48 -0.44 37.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.